Ontology highlight
ABSTRACT: Background
Diagnosis of Gleason 6 prostate cancer can leave uncertainty about the presence of undetected aggressive disease.Objective
To evaluate the utility of a four kallikrein (4K) panel in predicting the presence of high-grade cancer in men on active surveillance.Design, setting, and participants
Plasma collected before the first and subsequent surveillance biopsies was assessed for 718 men prospectively enrolled in the multi-institutional Canary PASS trial. Biopsy data were split 2:1 into training and test sets. We developed statistical models that included clinical information and either the 4Kpanel or serum prostate-specific antigen (PSA).Outcome measurements and statistical analysis
The endpoint was reclassification to Gleason ≥7. We used receiver op
SUBMITTER: Lin DW
PROVIDER: S-EPMC7327706 | biostudies-literature | 2017 Sep
REPOSITORIES: biostudies-literature